File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes

TitleInvolvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
Authors
Keywordsemergency departments
mesothelioma
palliative care
patient admission
survival
Issue Date2024
Citation
Current Oncology, 2024, v. 31, n. 2, p. 1028-1034 How to Cite?
AbstractMalignant pleural mesothelioma is a rare, aggressive, and incurable cancer with a poor prognosis and high symptom burden. For these patients, little is known about the impact of palliative care consultation on outcomes such as mortality, hospital admissions, or emergency department visits. The aim of this study is to determine if referral to supportive and palliative care in patients with malignant pleural mesothelioma is associated with survival and decreased hospital admissions and emergency department visits. This is a retrospective chart review. Study participants include all malignant pleural mesothelioma patients seen at The Ottawa Hospital—an acute care tertiary center—between January 2002 and March 2019. In total, 223 patients were included in the study. The mean age at diagnosis was 72.4 years and 82.5% were male. Of the patients diagnosed between 2002 and 2010, only 11 (9.6%) were referred to palliative care. By comparison, of those diagnosed between 2011 and 2019, 49 (45.4%) were referred to palliative care. Median time from diagnosis to referral was 4.1 months. There was no significant difference in the median survival of patients referred for palliative care compared to those who did not receive palliative care (p = 0.46). We found no association between receiving palliative care and the mean number of hospital admissions (1.04 vs. 0.91) from diagnosis to death, and an increase in mean number of emergency department visits in the palliative care group (2.30 vs. 1.18). Although there was increased utilization of palliative care services, more than half of the MPM patients did not receive palliative care despite their limited survival. There was an increase in emergency department visits in the palliative care group; this may represent an increase in the symptom burden (i.e., indication bias) in those referred to palliative care.
Persistent Identifierhttp://hdl.handle.net/10722/347096

 

DC FieldValueLanguage
dc.contributor.authorBaird, Andrew-
dc.contributor.authorNasser, Abdullah-
dc.contributor.authorTanuseputro, Peter-
dc.contributor.authorWebber, Colleen-
dc.contributor.authorWheatley-Price, Paul-
dc.contributor.authorMunro, Camille-
dc.date.accessioned2024-09-17T04:15:22Z-
dc.date.available2024-09-17T04:15:22Z-
dc.date.issued2024-
dc.identifier.citationCurrent Oncology, 2024, v. 31, n. 2, p. 1028-1034-
dc.identifier.urihttp://hdl.handle.net/10722/347096-
dc.description.abstractMalignant pleural mesothelioma is a rare, aggressive, and incurable cancer with a poor prognosis and high symptom burden. For these patients, little is known about the impact of palliative care consultation on outcomes such as mortality, hospital admissions, or emergency department visits. The aim of this study is to determine if referral to supportive and palliative care in patients with malignant pleural mesothelioma is associated with survival and decreased hospital admissions and emergency department visits. This is a retrospective chart review. Study participants include all malignant pleural mesothelioma patients seen at The Ottawa Hospital—an acute care tertiary center—between January 2002 and March 2019. In total, 223 patients were included in the study. The mean age at diagnosis was 72.4 years and 82.5% were male. Of the patients diagnosed between 2002 and 2010, only 11 (9.6%) were referred to palliative care. By comparison, of those diagnosed between 2011 and 2019, 49 (45.4%) were referred to palliative care. Median time from diagnosis to referral was 4.1 months. There was no significant difference in the median survival of patients referred for palliative care compared to those who did not receive palliative care (p = 0.46). We found no association between receiving palliative care and the mean number of hospital admissions (1.04 vs. 0.91) from diagnosis to death, and an increase in mean number of emergency department visits in the palliative care group (2.30 vs. 1.18). Although there was increased utilization of palliative care services, more than half of the MPM patients did not receive palliative care despite their limited survival. There was an increase in emergency department visits in the palliative care group; this may represent an increase in the symptom burden (i.e., indication bias) in those referred to palliative care.-
dc.languageeng-
dc.relation.ispartofCurrent Oncology-
dc.subjectemergency departments-
dc.subjectmesothelioma-
dc.subjectpalliative care-
dc.subjectpatient admission-
dc.subjectsurvival-
dc.titleInvolvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.3390/curroncol31020076-
dc.identifier.pmid38392070-
dc.identifier.scopuseid_2-s2.0-85185900606-
dc.identifier.volume31-
dc.identifier.issue2-
dc.identifier.spage1028-
dc.identifier.epage1034-
dc.identifier.eissn1718-7729-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats